Dan Chevallard
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dan Chevallard
Dan Chevallard is recorded as CFO at LENZ Therapeutics, Inc. (LENZ). LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Dan Chevallard was appointed Chief Financial Officer, effective March 21, 2024. Dan Chevallard has spoken on 6 earnings calls across 1 company, most recently for LENZ Therapeutics, Inc. on August 11, 2026.
“In addition, LENZ appointed Dan Chevallard as Chief Financial Officer, effective March 21, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at LENZ Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Evert Schimmelpennink CEO, Board Member
- Kimberlee C. Drapkin CEO, CFO, Chief Accounting Officer, Board Member
- Jeff George Chairman, Board Member
- Mr. George Chairman
- Daniel Chevallard CFO
- Katherine V. Stultz COO
- Continuing Directors Board Member
- Frederic Guerard Board Member
- James McCollum Board Member
- Shelley Thunen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.